Literature DB >> 20518598

The ketogenic diet: an appropriate first-line therapy?

Eric H Kossoff.   

Abstract

Mesh：

Year:  2010        PMID： 20518598     DOI： 10.1586/ern.10.35

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN： 1473-7175            Impact factor:   4.618


× No keyword cloud information.
  6 in total

1.  Transient use of a systemic adenosine kinase inhibitor attenuates epilepsy development in mice.

Authors:  Ursula S Sandau; Mayadah Yahya; Ryan Bigej; Joseph L Friedman; Bounmy Saleumvong; Detlev Boison
Journal:  Epilepsia       Date:  2019-02-27       Impact factor: 5.864

Review 2.  Progress in cell grafting therapy for temporal lobe epilepsy.

Authors:  Ashok K Shetty
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

3.  An update on the ketogenic diet, 2012.

Authors:  Ayelet Halevy; Lilach Peleg-Weiss; Roni Cohen; Avinoam Shuper
Journal:  Rambam Maimonides Med J       Date:  2012-01-31

4.  Is there a role for diet monotherapy in adult epilepsy?

Authors:  Mackenzie C Cervenka; Bobbie J Henry-Barron; Eric H Kossoff
Journal:  Epilepsy Behav Case Rep       Date:  2016-09-20

5.  In Vivo Estimation of Ketogenesis Using Metabolic Flux Analysis-Technical Aspects and Model Interpretation.

Authors:  Stanislaw Deja; Blanka Kucejova; Xiaorong Fu; Jeffrey D Browning; Jamey D Young; Shawn Burgess
Journal:  Metabolites       Date:  2021-04-28

6.  Specialty Grand Challenge for Brain Disease Mechanisms.

Authors:  Detlev Boison
Journal:  Front Mol Neurosci       Date:  2021-05-10       Impact factor: 5.639
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.